
Mark Hopman
15 stock trades in the last 12 months, shares they bought or sold themselves (not grants or options).
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
The 3 newest of 15 trades
| Stock | Trade | Amount | Traded |
|---|---|---|---|
| Sell(10b5-1 plan) | $13K | Nov 16SEC filing | |
| Sell(10b5-1 plan) | $6K | Nov 2SEC filing | |
| Sell(10b5-1 plan) | $16K | Oct 26SEC filing |
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Mark Hopman's companies
| Stock | Trades | Quality Score |
|---|---|---|
| 15 |
Alerts for Mark Hopman
Use this page
How to cite
Breakaway, Mark Hopman: Chief Commercial Officer at Beta Bionics (BBNX), Nov 18, 2026, getbreakaway.com/insiders/mark-hopman
Journalists: email support@getbreakaway.com for the data behind this page.